Home688185 • SHA
add
Cansino Biologics Inc
Previous close
¥73.76
Day range
¥73.15 - ¥75.76
Year range
¥48.50 - ¥92.70
Market cap
13.83B CNY
Avg Volume
2.27M
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 245.17M | 29.62% |
Operating expense | 215.85M | 12.80% |
Net income | -1.94M | 96.49% |
Net profit margin | -0.79 | 97.30% |
Earnings per share | — | — |
EBITDA | 12.74M | 233.79% |
Effective tax rate | 28.38% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.27B | -7.53% |
Total assets | 7.71B | -5.28% |
Total liabilities | 2.80B | -8.89% |
Total equity | 4.90B | — |
Shares outstanding | 308.51M | — |
Price to book | 4.64 | — |
Return on assets | -0.82% | — |
Return on capital | -0.93% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.94M | 96.49% |
Cash from operations | 25.08M | 123.65% |
Cash from investing | 151.84M | 153.33% |
Cash from financing | -100.53M | 61.43% |
Net change in cash | 72.32M | 111.06% |
Free cash flow | -52.32M | 72.13% |
About
CanSino Biologics, often abbreviated as CanSinoBIO, is a Chinese vaccine company. Wikipedia
CEO
Founded
Jan 13, 2009
Website
Employees
1,115
